Skip to main content

Table 1 Patient characteristics

From: Safety during interhospital helicopter transfer of ventilated COVID-19 patients. No clinical relevant changes in vital signs including non-invasive cardiac output

Gender M/F

69/29

Age (year)

62.3 ± 11.5

Weight (kg)

91.6 ± 16.7

Height (cm)

175 ± 9.4

Body Mass Index (kg m−2)

30.3 ± 6.0

Ventilation mode

 

 PCV

80 (82%)

  PEEP (cmH2O)

12.4 ± 2.2

  PC (cmH2O)

14.3 ± 2.7

 VCV

10 (10%)

  PEEP (cmH2O)

12.3 ± 2.6

  TV (ml)

407 ± 42

 PSV

8 (8%)

  PEEP (cmH2O)

10.7 ± 2.3

  PS (cmH2O)

8.7 ± 3.6

Trachea cannula

4 (4)

Inspired oxygen (%)

52 ± 12

Flight time (min)

56 ± 16

 Range (min)

35–149

Total flight time (min)

5497

Flight distance (km)

156 ± 46

 Range (km)

71–272

Total distance (km)

15,314

Sedation

 

 Midazolam

26 (27%)

 Propofol

24 (25%)

 Midazolam + Propofol

48 (49%)

 Opoids

91 (93%)

 Rocuronium

45 (46%)

Bolus number

 

 Sedation

70

 Opiods

20

 Rocuronium

45

 Vasoactive

14

Nor epinephrine

82 (84%)

 Mean dose ± SD (µg/kg/min)

0.07 ± 0.05

  1. Data are expressed as numbers, percentages, and mean ± standard deviation were appropriate
  2. PCV pressure control ventilation, PEEP positive end expiratory pressure, PC pressure control, VCV volume control ventilation, TV tidal volume, PSV pressure support ventilation, PS pressure support